Publicacións en colaboración con investigadores/as de Hospital Universitari de Girona Dr. Josep Trueta (15)

2019

  1. Associations between neuropsychological performance and appetite-regulating hormones in anorexia nervosa and healthy controls: Ghrelin's putative role as a mediator of decision-making

    Molecular and Cellular Endocrinology, Vol. 497

  2. Reduced Plasma Orexin-A Concentrations are Associated with Cognitive Deficits in Anorexia Nervosa

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. An increase in visceral fat is associated with a decrease in the taste and olfactory capacity

    PLoS ONE, Vol. 12, Núm. 2

2016

  1. A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women

    PLoS ONE, Vol. 11, Núm. 2

  2. Enduring Changes in Decision Making in Patients with Full Remission from Anorexia Nervosa

    European Eating Disorders Review, Vol. 24, Núm. 6, pp. 523-527

  3. Interaction Between Orexin-A and Sleep Quality in Females in Extreme Weight Conditions

    European Eating Disorders Review, Vol. 24, Núm. 6, pp. 510-517

  4. Modulation of irisin and physical activity on executive functions in obesity and morbid obesity

    Scientific Reports, Vol. 6

  5. Orexin and sleep quality in anorexia nervosa: Clinical relevance and influence on treatment outcome

    Psychoneuroendocrinology, Vol. 65, pp. 102-108

2015

  1. Changes in body composition in anorexia nervosa: Predictors of recovery and treatment outcome

    PLoS ONE, Vol. 10, Núm. 11

  2. Physical activity in anorexia nervosa: How relevant is it to therapy response?

    European Psychiatry, Vol. 30, Núm. 8, pp. 924-931

2014

  1. Relationship between eating styles and temperament in an Anorexia Nervosa, Healthy Control, and Morbid Obesity female sample

    Appetite, Vol. 76, pp. 76-83

  2. White fish reduces cardiovascular risk factors in patients with metabolic syndrome: The WISH-CARE study, a multicenter randomized clinical trial

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 24, Núm. 3, pp. 328-335

2013

  1. Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans

    PLoS ONE, Vol. 8, Núm. 6

2012

  1. Executive functions profile in extreme eating/weight conditions: From Anorexia Nervosa to Obesity

    PLoS ONE, Vol. 7, Núm. 8

2007

  1. Critical assessment of the current guidelines for the management and treatment of morbidly obese patients

    Journal of Endocrinological Investigation, Vol. 30, Núm. 10, pp. 844-852